Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,952.80
(
-0.26%
)
Dow Jones
46,946.41
(
0.00%
)
Brent Oil
99.92
(
1.64%
)
Bitcoin
74,100.27
(
-0.99%
)
News Focus
News Focus

Replies to post #64409 on Biotech Values

Replies to #64409 on Biotech Values
icon url

DewDiligence

07/18/08 7:50 AM

#64411 RE: DewDiligence #64409

Teva-Barr addendum: Inasmuch as BRL was emerging as a serious contender in the FoB arena (based on its 2007 acquisition of Pliva), the TEVA-BRL deal reduces the number of FoB players by one.